Tuesday, June 14, 2016
- 6:00pm-7:00pm
-
The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.
Poster Session D: Late Breaking • Halls C&D
- 6:00pm-7:00pm
-
Therapeutically Equivalent Results to Caucasians in Black Kidney Transplant Recipients Using ASTAGRAF XL® Despite a Higher Degree of HLA Mismatch : A Post-Hoc Analysis of Phase III Data from Over 2000 Patients.
Poster Session D: Late Breaking • Halls C&D
- 6:00pm-7:00pm
-
Three Months of Weekly Rifapentine Plus Isoniazid for Latent Tuberculosis Treatment in Solid Organ Transplant Candidates.
- 6:00pm-7:00pm
-
Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression.
- 6:00pm-7:00pm
-
Thrombotic Microangiopathy After Kidney Transplantation: A Rare but Serious Complication.